Dragon Pharma GHRP-6 10 mg Ghrelin Receptor Peptide Vial

Name: Dragon Pharma GHRP-6 10 mg Ghrelin Receptor Peptide Vial
Brand: Dragon Pharma
SKU: DP-GHRP6-PEP/USA
Price: 135.0 USD
Availability: InStock

Injection · 10 mg · vial

In stock · ships within 24h Out of stock

$135.00

Dragon Pharma GHRP-6 is a 10 mg lyophilized vial of the growth hormone-releasing hexapeptide, a ghrelin receptor agonist with the longest action and the loudest hunger signal in its family. It releases growth hormone and also touches ACTH and cortisol. Research material only.

GMP-manufactured, HPLC-verified with the Certificate of Analysis on file. GHRP-6 for sale with U.S. domestic and international shipping.

Shipping Not available in this combination

Discreet plain packaging

Worldwide reship guarantee

Crypto & card accepted

Product overview

Dragon Pharma GHRP-6 10 mg Research Vial

GHRP-6 is the growth hormone-releasing hexapeptide, a six amino acid ghrelin receptor agonist that has been in research hands since the 1980s under the development code SKF-110679. It releases growth hormone at the pituitary, and it is the family member most associated with appetite stimulation, which is exactly why it is chosen in some research settings and avoided in others. No country licenses it for human use, so the vial is documented as laboratory material with a single 10 mg pack option.

10 mg lyophilized powder per vial, one pack option
Ghrelin receptor agonist, the longest-acting ghrelin peptide
GMP-manufactured and HPLC-verified, COA per batch
U.S. domestic and international shipping options

How GHRP-6 Works

The peptide binds the ghrelin receptor on pituitary cells and triggers a growth hormone pulse, and it also activates the same receptor in the appetite centers, which is where the hunger comes from. A study in nine healthy volunteers measured a distribution phase of 7.6 plus or minus 1.9 minutes and a terminal half-life of 2.5 plus or minus 1.1 hours, noticeably longer than the short GHRP-2. Unlike the selective Ipamorelin, it raises ACTH and cortisol alongside growth hormone, so the release is not clean.

Reconstitution & Research Use

Add bacteriostatic water down the inside wall of the vial and swirl rather than shake. Ten milligrams with 2 ml gives 5 mg/ml, so 0.1 ml holds 500 mcg and reads as 10 units on a U-100 insulin syringe; 10 mg with 5 ml gives 2 mg/ml, where the same 10 units carry 200 mcg. Community material injects about thirty minutes before a meal or before sleep, on an empty stomach, and frequently alongside a GHRH analogue such as the CJC-1295 no DAC blend. Class side effects reported are appetite increase, fluid retention, joint discomfort and injection-site reactions.

Quality & Authenticity

Each batch is produced under GMP conditions and checked by HPLC, with a Certificate of Analysis held for the batch. Store the sealed powder at 2-8 C away from light and keep the reconstituted solution refrigerated.

For laboratory research only. Consult a healthcare professional before use.

Specifications

Brand	Dragon Pharma
Active Substance	GHRP-6
Dosage	10 mg per vial
Package	1 lyophilized vial
Form	Freeze-dried powder, requires reconstitution
Drug Class	Research peptide, GH secretagogue
Manufacturing	GMP-certified
Testing	HPLC per batch, COA on file
Shipping	U.S. domestic and international

Stacks

GHRP-6 Solo Course

Ten milligrams with 2 ml gives 500 mcg per 10 units, and vendor material describes one to three injections a day on an empty stomach, mostly before meals or before sleep.

Outcome: growth hormone release with a strong appetite signal, useful when food intake is the limiting factor.

GHRP-6 With A GHRH Analogue

Pairing it with a GHRH arm such as the CJC-1295 DAC 5 mg vial is the classic two-receptor arrangement in community logs.

Outcome: two receptor paths for one output, with no controlled study of the pair.

Rotating Toward A Cleaner Release

When cortisol or constant hunger becomes a problem, users switch to Ipamorelin 5 mg or the shorter Hexarelin 5 mg.

Outcome: less appetite and less stress-axis noise, with the same research-only status.

FAQ

Before you ask

Questions, answered

GHRP-6 is a six amino acid peptide, the growth hormone-releasing hexapeptide, that acts as a ghrelin receptor agonist. It triggers growth hormone release from the pituitary and simultaneously activates the same receptor in appetite centers, which is why increased hunger is treated as its signature. It has no licensed human use and is sold as research material.

A study in nine healthy volunteers gives a distribution phase of 7.6 plus or minus 1.9 minutes and a terminal half-life of 2.5 plus or minus 1.1 hours, which makes it the longest-acting ghrelin peptide of the group. The short distribution phase explains the fast onset, and the longer terminal phase explains why the appetite effect outlasts the growth hormone spike.

Add bacteriostatic water slowly down the glass wall and swirl it, never shake. With 2 ml the vial is 5 mg/ml, so 0.1 ml carries 500 mcg; with 5 ml it is 2 mg/ml and the same 10 units on a U-100 syringe hold 200 mcg. The larger volume is easier to measure accurately, which matters when the smallest graduation is frustrating to read.

Hunger is the expected one and can be strong enough to be a problem during a cutting phase. The class also reports fluid retention, joint and muscle aches, and injection-site reactions, and GHRP-6 raises ACTH and cortisol rather than leaving the stress axis untouched. There is no human hepatic data for the peptide and no side-effect frequency table from a controlled trial.

The 10 mg vial is listed on this page as research material and ships with U.S. domestic and international options, with price and stock shown against the selector. Growth hormone secretagogues such as GHRP-6 sit in WADA class S2 and are prohibited at all times, so anyone subject to testing should treat the vial as an automatic positive rather than a grey area.

No reviews yet

Be the first to share your experience with Dragon Pharma GHRP-6 10 mg Ghrelin Receptor Peptide Vial

Complete the cycle